[New recognition of a role of dyslipidemia and lipid-lowering treatment in pathogenesis of renal disease].
Li
Xue-wang
XW
Li
Hang
H
D000818:Animals; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000188:drug therapy* / Q000209:etiology
D000960:Hypolipidemic Agents